Investor Presentaiton

Danaher Today D DANAHER ~$31.5B 2022 TOTAL REVENUE All financial metrics reflect FY 2022 results. 4 BIOTECHNOLOGY ~$8.8B LIFE SCIENCES ~$7.0B cytiva PALL Life Sciences BECKMAN Leica COULTER Life Sciences MICROSYSTEMS XXIDT INTEGRATED DNA KORNGLOGES DIAGNOSTICS ~$10.8B BECKMAN Cepheid. COULTER ENV. & APPLIED ~$4.8B HACH SCIEX PALL Industrial aldevron Leica RADIOMETER® BIOSYSTEMS ChemTreat technologies" VIDEOJET. TROJAN ESKO⭑ ☑x-rite PANTONEⓇ Purpose-driven science & technology leader DANAHER

View entire presentation